Tirzepatide (Zepbound) has indeed shown promising results in clinical trials regarding weight loss in people with type 2 diabetes. In some studies, participants experienced significant weight loss, often around 10% or more of their initial body weight.

However, whether someone can lose exactly 20% of their body weight with Tirzepatide would depend on various factors, including their starting weight, adherence to treatment, lifestyle changes, and individual response to the medication.

It’s essential to approach weight loss goals with realistic expectations and under the guidance of healthcare professionals. While Tirzepatide may aid in weight loss, it’s typically most effective when combined with a healthy diet, regular exercise, and other lifestyle modifications. Always consult with a healthcare provider for personalized advice and recommendations.